Med (New York, N.Y.) - JoVE Visualize

Showing results (851-860 of 867) with videos related to

Pageof 87

Sort By:

Med (New York, N.Y.)|July 29, 2026

Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanomaLilit Karapetyan, Jin Xu, Kimberly Ward, et al.

Med (New York, N.Y.)|July 30, 2026

Gene therapy for hypertrophic cardiomyopathy: From feasibility to a fieldwide frameworkMilind Y Desai, Susan K Keen, Eugene Braunwald

Med (New York, N.Y.)|July 22, 2026

Ethics of gene therapyJulian Savulescu, Sebastian Porsdam Mann, Christopher Gyngell, et al.

Med (New York, N.Y.)|August 19, 2026

Multiomics profiling of plasma reveals lipid-immune dysregulation and exosome remodeling in mpox and mpox-HIV co-infectionSiqi Yong, Jiaying Zhang, He Tian, et al.

Med (New York, N.Y.)|September 9, 2026

Cardiovascular-kidney-metabolic syndrome and the risk of liver-related and cardiovascular events across the steatotic liver disease spectrumQiong-Yue Fan, Li-You Lian, Tian-Yi Xia, et al.

Med (New York, N.Y.)|September 11, 2026

Prenatal exposure to the plasticizer DEHP increases the likelihood of early-life autism and ADHD symptoms through epigenetic programmingSamuel Tanner, Alex Eisner, Boris Novakovic, et al.

Med (New York, N.Y.)|August 14, 2026

Daraxonrasib in refractory PDAC: A one-eyed king in the land of the blind?Giulia Orsi, Michele Reni

Med (New York, N.Y.)|August 14, 2026

Reprogramming HER2-Positive gastroesophageal cancer immune contexture with bispecific therapy: HERIZON-GEA-01Raghav Sundar, Samuel J Klempner

Med (New York, N.Y.)|August 17, 2026

Concomitant lipid-lowering and anticoagulation therapy for recurrent venous thromboembolism prevention: A Bayesian meta-analysisHarsini Raaja Sulochana, Yufan Yang, Laura Bindila, et al.

Med (New York, N.Y.)|August 14, 2026

Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trialRun-Cong Nie, Shi Chen, Jin Wan, et al.

Pageof 87

Showing results (851-860 of 867) with videos related to

Sort By:

Pageof 87

Med (New York, N.Y.)|July 29, 2026

Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanomaLilit Karapetyan, Jin Xu, Kimberly Ward, et al.

Med (New York, N.Y.)|July 30, 2026

Gene therapy for hypertrophic cardiomyopathy: From feasibility to a fieldwide frameworkMilind Y Desai, Susan K Keen, Eugene Braunwald

Med (New York, N.Y.)|July 22, 2026

Ethics of gene therapyJulian Savulescu, Sebastian Porsdam Mann, Christopher Gyngell, et al.

Med (New York, N.Y.)|August 19, 2026

Multiomics profiling of plasma reveals lipid-immune dysregulation and exosome remodeling in mpox and mpox-HIV co-infectionSiqi Yong, Jiaying Zhang, He Tian, et al.

Med (New York, N.Y.)|September 9, 2026

Cardiovascular-kidney-metabolic syndrome and the risk of liver-related and cardiovascular events across the steatotic liver disease spectrumQiong-Yue Fan, Li-You Lian, Tian-Yi Xia, et al.

Med (New York, N.Y.)|September 11, 2026

Prenatal exposure to the plasticizer DEHP increases the likelihood of early-life autism and ADHD symptoms through epigenetic programmingSamuel Tanner, Alex Eisner, Boris Novakovic, et al.

Med (New York, N.Y.)|August 14, 2026

Daraxonrasib in refractory PDAC: A one-eyed king in the land of the blind?Giulia Orsi, Michele Reni

Med (New York, N.Y.)|August 14, 2026

Reprogramming HER2-Positive gastroesophageal cancer immune contexture with bispecific therapy: HERIZON-GEA-01Raghav Sundar, Samuel J Klempner

Med (New York, N.Y.)|August 17, 2026

Concomitant lipid-lowering and anticoagulation therapy for recurrent venous thromboembolism prevention: A Bayesian meta-analysisHarsini Raaja Sulochana, Yufan Yang, Laura Bindila, et al.

Med (New York, N.Y.)|August 14, 2026

Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trialRun-Cong Nie, Shi Chen, Jin Wan, et al.

Pageof 87